Arthrosi's gout drug financed with $75 million Series D : co

The U.S. company Arthrosi Therapeutics has bagged $75 million in a Series D round to fund the clinical development of a small molecule drug for chronic gout.

Related Keywords

China , Litain Yeh , Ruiao Biopharmaceutical Technology , Reichstein Biotech Hk Co , Guangrun Health Industry , Apichope Pharmaceuticals , Reichstein Biotech , Investigational New Drug , Markets Amp Regulations , Linical Evolution , Financing Round , Small Molecule Drugs , Small Molecule ,